SALT
LAKE CITY, Jan. 30, 2025 /PRNewswire/ --
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"),
a molecular diagnostics company with a unique, patented platform
for the development of molecular diagnostic tests, announced that
it will be hosting a booth at BioUtah's Life Sciences Day on the
Hill today at the Utah State Capitol Rotunda.
The Life Sciences Day on the Hill is presented by the Utah Life
Sciences Innovation Caucus, the Utah Governor's Office of Economic
Opportunity, and BioUtah, an independent trade association serving
the life sciences community in Utah. BioUtah is comprised of manufacturers
and developers of medical devices, pharmaceuticals, diagnostics and
biotechnology products as well as government, academic and health
care institutions all focused on improving health and wellness
through the delivery of innovative technologies and services.
The event follows the Company's participation with the
Utah Governor's Office of Economic
Opportunity on the World Trade Center Utah's trade mission to
Asia last fall, and continues
Co-Dx's outreach to strengthen global and local relationships.
This year's event takes place today, January 30, from 11:00 AM
to 2:00 PM MST, and is expected to feature exhibits from
over 25 Utah life sciences companies. Co-Dx's booth will showcase
the Company's upcoming at-home and point-of care Co-Dx PCR testing
platform* for detection of infectious diseases, including COVID-19,
influenza, RSV, HPV and tuberculosis. The platform also
incorporates cloud-based analysis to help build situational
awareness and provide support to track infectious disease outbreaks
at the community and regional level, all operated via an intuitive
smartphone interface.
*The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx
PCR Pro™, mobile app, and all associated tests and software) is
subject to review by the FDA and/or other regulatory bodies and is
not available for sale. The Co-Dx PCR Pro instrument and Co-Dx
COVID-19 Test are currently under review by the FDA.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
Utah corporation, is a molecular
diagnostics company that develops, manufactures and markets
state-of-the-art diagnostics technologies. The Company's
technologies are utilized for tests that are designed using the
detection and/or analysis of nucleic acid molecules (DNA or RNA).
The Company also uses its proprietary technology to design specific
tests for its Co-Dx PCR at-home and point-of-care platform and to
locate genetic markers for use in applications other than
infectious disease.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-exhibit-at-bioutahs-2025-life-sciences-day-on-the-hill-302364228.html
SOURCE Co-Diagnostics
